To further validate the inhibitive effect of RIPK1 on AQP1-driven TNBC development, an orthotopic breast carcinoma mouse model was established by injecting transgenic 4T1 cells into the mammary fat pad of BALB/c mice (Fig. 5A). The gene discussed is RIPK1; the disease is breast carcinoma.